The market is highly competitive, with over 60 companies developing GLP-1 drugs and more than 135 candidates in clinical trials
If you have underlying health conditions like issues with your heart health, speak with your healthcare provider before making any major changes to your physical activity
At MDC, we make it easy to include: eGFR and U&E for kidney function Lipid and cardiac enzymes for heart risk Inflammation markers for early signs of vascular damage Book Your Diabetes Monitoring in Central London If you are: Living with Type 2 Diabetes Considering Mounjaro or Retatrutide Already using weight-loss injections Or simply want reassurance about your long-term health Book a Diabetes Profile, Cardiac Profile 2, or Marylebone Health Screening at MDC today

In such circumstances: Contact emergency services (999) or attend the nearest Accident & Emergency department Call NHS 111 for urgent but non-life-threatening concerns Contact your local NHS urgent mental health helpline (search online for 'NHS urgent mental health helpline' and your location) Call the Samaritans (116 123, available 24/7) for immediate emotional support Do not leave the person alone if they are at immediate risk For non-emergency concerns about mood changes whilst taking GLP-1 agonists, patients should contact their GP or diabetes specialist nurse within 2448 hours
MT2 was first developed in the 1990s by researchers Victor J